Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Global prescription drug spend seen at 1.5 trillion dollars by 2021: report

      Global prescription drug spend seen at 1.5 trillion dollars by 2021: report

      supriya kashyap kashyap6 Dec 2016 11:32 AM IST
      Global spending on prescription medicines will reach nearly $1.5 trillion by 2021, although the annual rate of growth will decrease from recent years,...
      Study raises questions over benefit of Roche Gazyva cancer drug

      Study raises questions over benefit of Roche Gazyva cancer drug

      supriya kashyap kashyap6 Dec 2016 11:23 AM IST
      Roche's Gazyva cancer drug did not show a significant overall survival benefit and raised greater safety concerns than its predecessor Rituxan, a...
      Lupin gets USFDA final nod for pain relief tablets

      Lupin gets USFDA final nod for pain relief tablets

      supriya kashyap kashyap6 Dec 2016 11:22 AM IST
      New Delhi : Drug firm Lupin has received final approval from the US health regulator for its Hydrocodone Bitartrate and Acetaminophen tablets used...
      Dr Reddys launches anti-fungal ointment in the US

      Dr Reddys launches anti-fungal ointment in the US

      supriya kashyap kashyap6 Dec 2016 11:22 AM IST
      New Delhi : Dr Reddy's Laboratories Ltd announced the launch of anti-fungal ointment nystatin and triamcinolone acetonide in the US market.In a BSE...
      Kiran Mazumdar-Shaw silences Twitter trolls with a 78 percent Biocon stock rally

      Kiran Mazumdar-Shaw silences Twitter trolls with a 78 percent Biocon stock rally

      supriya kashyap kashyap5 Dec 2016 1:25 PM IST
      Mumbai : For more than two years Kiran Mazumdar-Shaw had a quarterly date with her Twitter trolls.Every three months, after her Bangalore-based...
      Lupin partners Eli Lilly to market diabetes drug Eglucent

      Lupin partners Eli Lilly to market diabetes drug Eglucent

      supriya kashyap kashyap5 Dec 2016 9:12 AM IST
      New Delhi : Pharma major Lupin announced a new partnership with Eli Lilly India to market and sell the latter's diabetes treatment drug 'Eglucent'...
      FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

      FDA approves Jardiance to reduce cardiovascular death in adults with type 2 diabetes

      supriya kashyap kashyap4 Dec 2016 1:11 PM IST
      The U.S. Food and Drug Administration approved a new indication for Jardiance (empagliflozin) to reduce the risk of cardiovascular death in adult...
      Medical device maker Teleflex to buy Vascular Solutions for $1 billion

      Medical device maker Teleflex to buy Vascular Solutions for $1 billion

      supriya kashyap kashyap4 Dec 2016 11:10 AM IST
      Teleflex Inc said it agreed to buy fellow medical device maker Vascular Solutions Inc for about $1 billion.Teleflex's offer of $56 per Vascular share...
      Amgen, Allergan apply for European nod for Avastin biosimilar

      Amgen, Allergan apply for European nod for Avastin biosimilar

      supriya kashyap kashyap4 Dec 2016 10:15 AM IST
      Amgen Inc and Allergan Plc said they have submitted an application to the European health regulator seeking approval of their biosimilar version of...
      IFC plans to invest 200-300 million dollars in healthcare sector

      IFC plans to invest 200-300 million dollars in healthcare sector

      supriya kashyap kashyap4 Dec 2016 10:15 AM IST
      The World Bank's private lending arm International Finance Corporation (IFC) is exploring the possibility of investing $200-300 million in Indian...
      Janssen announces introduction of Connect for Life programme

      Janssen announces introduction of Connect for Life programme

      supriya kashyap kashyap3 Dec 2016 11:10 AM IST
      Hyderabad : Janssen, the pharmaceutical companies of Johnson & Johnson, announced that Connect for Life, a human immunodeficiency virus (HIV)...
      Momentas Humira biosimilar succeeds in key psoriasis study

      Momenta's Humira biosimilar succeeds in key psoriasis study

      supriya kashyap kashyap3 Dec 2016 11:07 AM IST
      U.S. biotech Momenta Pharmaceuticals Inc said its experimental biosimilar version of AbbVie Inc's top-selling autoimmune drug, Humira, met the main...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok